Flumequine (CAS 42835-25-6) is a first-generation fluoroquinolone antibiotic that has established a significant presence in the global veterinary pharmaceutical market. As a synthetic chemotherapeutic agent, it is primarily utilised for treating bacterial infections in food-producing animals, particularly enteric infections caused by gram-negative organisms. The compound has found extensive application in aquaculture, poultry, swine, and cattle production systems across multiple continents. For pharmaceutical ingredient suppliers, veterinary drug manufacturers, and international traders, access to a verified Flumequine global buyers list represents a critical commercial asset. The global Flumequine market operates through a concentrated network of importers, distributors, and end-users, with India emerging as the dominant export hub and Vietnam leading import activity.…